A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor (TKI) Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

367

Participants

Timeline

Start Date

March 17, 2017

Primary Completion Date

January 20, 2022

Study Completion Date

October 17, 2022

Conditions
Non-Small-Cell Lung Carcinoma
Interventions
BIOLOGICAL

Nivolumab

Specified dose on specified days

BIOLOGICAL

Ipilimumab

Specified dose on specified days

DRUG

Pemetrexed

Specified dose on specified days

DRUG

Cisplatin

Specified dose on specified days

DRUG

Carboplatin

Specified dose on specified days

Trial Locations (109)

0

Local Institution - 0027, Hong Kong

112

Local Institution - 0023, Taipei

114

Local Institution, Taipei

333

Local Institution, Taoyuan District

704

Local Institution - 0021, Tainan City

736

Local Institution, Tainan City

807

Local Institution, Kaohsiung City

10002

Local Institution, Taipei

10016

Local Institution - 0064, New York

10408

Local Institution, Gyeonggi-do

10449

Local Institution - 0066, Taipei

11031

Local Institution - 0108, Taipei

13915

Local Institution, Marseille

19111

Fox Chase Cancer Center, Philadelphia

21205

Johns Hopkins University, Baltimore

28041

Local Institution, Madrid

28222

Local Institution, Majadahonda

29010

Local Institution, Málaga

31059

Local Institution, Toulouse

35033

Local Institution, Rennes

40447

Local Institution - 0018, Taichung

40705

Local Institution, Taichung

50009

Local Institution, Zaragoza

60637

Local Institution - 0004, Chicago

62247

Local Institution - 0045, Chiayi City

75005

Local Institution - 0156, Paris

75701

Local Institution - 0063, Tyler

76012

Texas Health Physicians Group, Arlington

76508

Baylor Scott and White Research Institute, Temple

82445

Local Institution, Kaohsiung City

83301

Local Institution - 0019, Kaohsiung City

84112

Local Institution - 0001, Salt Lake City

90017

Local Institution - 0029, Los Angeles

90095

Local Institution - 0033, Los Angeles

90277

Torrance Memorial Physican Network, Redondo Beach

90808

Pacific Shores Medical Group, Long Beach

92868

Local Institution - 0061, Orange

100730

Local Institution, Beijing

100853

Local Institution, Beijing

119074

Local Institution - 0042, Singapore

130012

Local Institution, Changchun

130021

Local Institution, Changchun

200025

Local Institution, Shanghai

200030

Local Institution, Shanghai

308433

Local Institution - 0041, Singapore

310006

Local Institution - 0016, Hangzhou

310011

Local Institution - 0017, Hangzhou

310016

Local Institution, Hangzhou

400042

Local Institution, Chongqing

410013

Local Institution - 0043, Changsha

450008

Local Institution, Zhengzhou

510000

Local Institution, Guangzhou

610041

Local Institution, Chengdu

710032

Local Institution, Xi'an

1138603

Local Institution, Bunkyō City

1358550

Local Institution - 0078, Koto-ku

1600023

Local Institution - 0079, Tokyo

2210855

Local Institution - 0081, Yokohama

2608670

Local Institution, Chiba

4648681

Local Institution, Nagoya

5968501

Local Institution, Kishiwada Shi

6418510

Local Institution, Wakayama

6500047

Local Institution, Kobe

6648540

Local Institution - 0097, Itami

6708520

Local Institution, Himeji-shi

7210971

Local Institution, Fukuyama

7348551

Local Institution, Hiroshima

7550241

Local Institution, Ube Shi

8208505

Local Institution, Iizuka

9601295

Local Institution, Fukushima

9630197

Local Institution, Kōriyama

9800873

Local Institution - 0077, Sendai

06520

Local Institution - 0003, New Haven

02114

Local Institution - 0002, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston

27509-1626

Duke University Medical Center, Butner

T6G 1Z2

Local Institution - 0166, Edmonton

H4A3J1

Local Institution - 0168, Montreal

Unknown

Local Institution, Hong Kong

Local Institution - 0024, Hong Kong

Local Institution, Shatin

036-8174

Local Institution, Hirosaki-shi

791-0280

Local Institution, Matsuyama

830-0011

Local Institution - 0059, Kurume

003-0804

Local Institution - 0070, Sapporo

236-0051

Local Institution, Yokohama

241-8515

Local Institution, Yokohama

861-4193

Local Institution, Kumamoto

981-1293

Local Institution, Natori-shi

573-1191

Local Institution, Hirakata-shi

591-8555

Local Institution, Sakai

589-8511

Local Institution - 0058, Sayama

350-1298

Local Institution - 0076, Hidaka

362-0806

Local Institution, Kitaadachi-gun

104-0045

Local Institution - 0069, Chūō

810-0001

Local Institution, Fukuoka

812-8582

Local Institution, Fukuoka

990-9585

Local Institution, Niigata

930-8550

Local Institution, Toyama

03722

Local Institution - 0038, Seoul

05505

Local Institution - 0037, Seoul

06351

Local Institution - 0035, Seoul

361-711

Local Institution, Cheogju-si

463-707

Local Institution - 0036, Gyeonggi-do

405-760

Local Institution, Inchoen

06591

Local Institution, Seoul

08035

Local Institution - 0158, Barcelona

08907

Local Institution, L'Hospitalet de Llobregat

Sponsors
All Listed Sponsors
collaborator

Ono Pharmaceutical Co. Ltd

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY